CRISPR Therapeutics
CRSP
#3276
Rank
โ‚ฌ3.94 B
Marketcap
41,38ย โ‚ฌ
Share price
6.23%
Change (1 day)
5.83%
Change (1 year)

EPS for CRISPR Therapeutics (CRSP)

EPS in 2025 (TTM): -4,92ย โ‚ฌ

According to CRISPR Therapeutics's latest financial reports the company's current EPS (TTM) is -4,75ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -3,71ย โ‚ฌ.

EPS history for CRISPR Therapeutics from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-4,92ย โ‚ฌ32.5%
2024-3,71ย โ‚ฌ
2022-7,11ย โ‚ฌ-267.74%
20214,24ย โ‚ฌ
20190,94ย โ‚ฌ-132.36%
2018-2,91ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-1,47ย โ‚ฌ-69.05%๐Ÿ‡บ๐Ÿ‡ธ USA